000 01184 a2200349 4500
005 20250514214423.0
264 0 _c20050202
008 200502s 0 0 eng d
022 _a1538-3598
024 7 _a10.1001/jama.293.3.358
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChoudhry, Niteesh K
245 0 0 _aA perspective on US drug reimportation.
_h[electronic resource]
260 _bJAMA
_cJan 2005
300 _a358-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCanada
650 0 4 _aCommerce
650 0 4 _aCost Control
650 0 4 _aDrug Industry
_xlegislation & jurisprudence
650 0 4 _aDrug and Narcotic Control
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFees, Pharmaceutical
650 0 4 _aHumans
650 0 4 _aInternationality
650 0 4 _aPharmaceutical Preparations
_xeconomics
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aDetsky, Allan S
773 0 _tJAMA
_gvol. 293
_gno. 3
_gp. 358-62
856 4 0 _uhttps://doi.org/10.1001/jama.293.3.358
_zAvailable from publisher's website
999 _c15336415
_d15336415